WASHINGTON (Reuters) - U.S. politicians condemned Pfizer Inc's deal with Allergan Plc as a tax dodge on Monday, bringing another round of hand-wringing in Washington over the corporate tax code, though legislative action before 2017 is unlikely.













Source: Politicians slam tax-avoiding Pfizer-Allergan mega-deal


David Cottle

UBB Owner & Administrator